IL4 and myeloid sarcoma: MMP7 cleaves fibronectin aggregates, and its proenzyme proMMP7, which is mostly produced by alternative (IL-4)-activated microglia and macrophages, is expressed poorly in chronic MS lesions relative to shadow plaques, in part explaining the failure of remyelination in these lesions [151].